Vascular Biogenics Ltd. (VBLT) is trading at unusually high volume Friday with 5.4 million shares changing hands. It is currently at more than 50x its average daily volume and trading up $1.43, or 30.60% at $6.20 as of 11:54 p.m. ET. Not seeing any news to account for the move.
Vascular Biogenics is set to report Q4 results and full year 2014 financial results on March 25. The clinical-stage biopharmaceutical Yehuda, Israel-based company has a market cap of $199 million. Shares have advanced 6.52% in the last 4 weeks while declining 19.80% in the past three months. Over the past 5 trading sessions the stock has gained 47.20%. Shares of Vascular Biogenics Ltd. are down 19.80% this year.
The name has a median Wall Street price target of $11.50 with a high target of $13.00